This panel discussion focuses on the medical management of benign prostatic hyperplasia and lower urinary tract symptoms.
The discussion reviews commonly used therapies, including alpha blockers such as tamsulosin, and highlights alternative options that may reduce side effects such as...
Abstract
Benign prostatic hyperplasia affects up to 80% of men in their lifetime. It causes bladder outflow obstruction, leading to lower urinary tract symptoms, which can have a large impact on quality of life. Lifestyle modifications and pharmacotherapy are often offered as first-line...